REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorio Farnatec Ltda Laboratorio de Farmacologia Natural y Tecnologia Limitada (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorio Farnatec Ltda Laboratorio de Farmacologia Natural y Tecnologia Limitada Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

The company Farnatec Ltda Farmacologia Natural Y Tecnologia Ltda is primarily engaged in drugs and druggists' sundries merchant wholesalers and related activities. It's been operating in the Colombian market since 2010.

Headquarters
Cra.26D Bis N.32A-01 Sur
Bogota D.C.; Bogota D.C; Postal Code: 0310

Contact Details: Purchase the Laboratorio Farnatec Ltda Laboratorio de Farmacologia Natural y Tecnologia Limitada report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Farnatec Ltda Laboratorio de Farmacologia Natural y Tecnologia Limitada report to view the information.
Outstanding Shares:
Purchase the Laboratorio Farnatec Ltda Laboratorio de Farmacologia Natural y Tecnologia Limitada report to view the information.
Incorporation Date:
September 23, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorio Farnatec Ltda Laboratorio de Farmacologia Natural y Tecnologia Limitada report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-8.01%▼
Total operating revenue
-8.01%▼
Operating profit (EBIT)
-5.06%▼
Net Profit (Loss) for the Period
-80.35%▼
Total assets
65.28%▲
Total equity
N/A
Operating Profit Margin (ROS)
0.35%▲
Net Profit Margin
-8.52%▼
Return on Equity (ROE)
N/A
Quick Ratio
0.54%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo